Dong-Geng Liu

Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial

Xi-Chun Hu, Jian Zhang, Bing-He Xu et al. · The Lancet Oncology · 2015 · 285 citations

Medicine, Oncology, Pharmacology +15

Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: a retrospective analysis of 192 cases at a single center

Jing Wei, Yu-Ting Tan, Yu-Cen Cai et al. · Chinese Journal of Cancer · 2014 · 89 citations · Full text

Medicine, Oncology, Surgery +17

Lapatinib plus capecitabine in treating HER2-positive advanced breast cancer: efficacy, safety, and biomarker results from Chinese patients

Bing-He Xu, Ze-Fei Jiang, Daniel T. T. Chua et al. · Chinese Journal of Cancer · 2011 · 45 citations · Full text

Medicine, Oncology, Pharmacology +16

Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancer

Yan-Xia Shi, Qing Xia, Roujun Peng et al. · Journal of Cancer Research and Clinical Oncology · 2012 · 44 citations · Full text

Medicine, Oncology, Pathology +10